Mild

Krause’s Bulboma - Causes, Treatment & When to See a Doctor

📅 Updated: May 2026 ⏱️ 5 min read ✅ Medically reviewed

Contents

Krause’s Bulboma – Causes, Symptoms, Diagnosis & Treatment

Krause’s Bulboma: A Complete Guide

What is Krause’s Bulboma?

Krause’s bulboma is a rare, benign proliferative lesion that originates from the Krause’s tubercles (also called Krause’s glands) – small, mucus‑secreting sweat‑type glands located in the conjunctival fornix and the inner surface of the eyelid. These glands are part of the ocular accessory lacrimal system and help maintain surface moisture. A bulboma represents an abnormal overgrowth of the glandular epithelium resulting in a small, cyst‑like nodule that may be sessile or pedunculated.

Although the term “bulboma” suggests a tumor, the lesion is typically non‑malignant and slow‑growing. It is most often discovered incidentally during routine eye examinations or when patients notice a painless lump on the inner eyelid. When inflamed, the lesion can become red, tender, or even ulcerated, mimicking more serious conditions such as chalazia or conjunctival neoplasms.

Common Causes

The exact trigger for Krause’s bulboma is not fully understood, but several factors appear to increase the likelihood of glandular hyperplasia. Below are the most frequently reported associations:

  • Chronic Ocular Irritation: Repeated friction from contact lenses, eye rubbing, or foreign bodies.
  • Blepharitis: Inflammation of the eyelid margin can spread to accessory glands.
  • Meibomian Gland Dysfunction (MGD): Altered lipid secretion creates a stagnant environment encouraging glandular overgrowth.
  • Allergic Conjunctivitis: Persistent allergic inflammation may stimulate glandular proliferation.
  • Solar UV Exposure: Long‑term sunlight exposure can damage ocular surface cells, leading to reactive hyperplasia.
  • Autoimmune Disorders: Conditions such as Sjögren’s syndrome or lupus may affect lacrimal tissue.
  • Systemic Medications: Long‑term use of isotretinoin, antihistamines, or systemic steroids has been linked to glandular changes.
  • Age‑Related Degeneration: Elderly patients experience atrophy and compensatory hyperplasia of remaining glands.
  • Infectious Agents: Rarely, bacterial or viral conjunctivitis can precipitate a reactive bulboma.
  • Genetic Predisposition: Family history of accessory gland tumors may confer susceptibility.

Associated Symptoms

Many patients with Krause’s bulboma remain asymptomatic, but when the lesion grows or becomes inflamed, the following signs may appear:

  • Small, raised nodule (1‑5 mm) on the inner eyelid or conjunctival fornix.
  • Watery or mucoid discharge if the gland continues to secrete.
  • Localized redness and mild swelling.
  • Occasional itching or a gritty sensation.
  • Blurred vision if the lesion protrudes onto the cornea.
  • Secondary bacterial infection leading to pus formation.
  • Rarely, a palpable hardening that may be mistaken for a malignant lesion.

When to See a Doctor

Most bulbomas are benign, but certain changes warrant prompt evaluation by an eye care professional (optometrist or ophthalmologist):

  • Rapid increase in size over days to weeks.
  • Persistent pain, throbbing, or tenderness.
  • Visible ulceration, bleeding, or pus.
  • Changes in vision such as double vision or persistent blurriness.
  • New-onset photophobia (light sensitivity) or excessive tearing.
  • Any suspicion that the lesion might be malignant (irregular borders, dark pigmentation).

Diagnosis

Accurate diagnosis involves a combination of clinical observation and ancillary testing:

1. Clinical Examination

  • Slit‑lamp biomicroscopy: Allows magnified inspection of the lesion’s size, shape, and vascular pattern.
  • Eversion of the eyelid: Helps expose hidden bulboma in the fornix.
  • Fluorescein staining: Detects epithelial breakdown or ulceration.

2. Imaging Studies (when needed)

  • Anterior segment optical coherence tomography (AS‑OCT): Provides cross‑sectional images to differentiate cystic versus solid components.
  • Ultrasound biomicroscopy: Useful for deep lesions or when the diagnosis is uncertain.

3. Laboratory Tests

  • If infection is suspected, a swab for bacterial culture and Gram stain may be taken.
  • In cases where malignancy cannot be excluded, a biopsy (excisional or incisional) is performed and sent for histopathology.

4. Differential Diagnosis

Physicians compare the lesion to several other conditions, including:

  • Chalazion
  • Conjunctival papilloma
  • Squamous cell carcinoma of the conjunctiva
  • Dermoid cysts
  • Allergic papillae

Treatment Options

Management depends on symptom severity, lesion size, and patient preference.

Conservative / Home Care

  • Warm compresses: 10‑15 minutes, 3–4 times daily to promote natural drainage.
  • Lid hygiene: Gentle cleansing with diluted baby shampoo or lid‑scrub solutions.
  • Artificial tears: Preserve ocular surface moisture and reduce irritation.
  • Allergy control: Antihistamine eye drops or oral antihistamines for allergic contributors.
  • Avoidance of irritants: Discontinue contact lens wear until the lesion resolves, and protect eyes from wind and UV light (sunglasses).

Medical Therapies

  • Topical antibiotics: E.g., moxifloxacin 0.5 % drops if secondary bacterial infection is present.
  • Topical steroids: Short courses (e.g., prednisolone acetate 1 %) for marked inflammation, but used cautiously to avoid cataract or glaucoma.
  • Oral doxycycline: 100 mg twice daily for 2‑4 weeks; its anti‑inflammatory properties help with chronic blepharitis and MGD.

Surgical Interventions

When conservative measures fail or the lesion threatens vision, procedural options are considered:

  • Incision and curettage: Small lesions are opened and the proliferative tissue is gently scraped out.
  • Excisional biopsy: Complete removal of the bulboma with histopathological confirmation; the preferred method for suspicious lesions.
  • Laser ablation: Low‑power CO₂ or Nd:YAG laser can vaporize superficial lesions with minimal scarring.
  • Cryotherapy: Freezing the lesion for small, well‑delineated nodules.

Post‑procedure Care

  • Topical antibiotics for 5‑7 days.
  • Patch the eye for 24 hours only if instructed.
  • Follow‑up slit‑lamp exam within 1–2 weeks.

Prevention Tips

While not all cases can be prevented, the following habits lower the risk of developing a bulboma or keep existing lesions from worsening:

  • Maintain diligent eyelid hygiene—clean lids daily, especially if you wear contact lenses.
  • Use protective eyewear (UV‑blocking sunglasses) when outdoors.
  • Limit eye rubbing; treat itchiness with antihistamine drops rather than mechanical irritation.
  • Manage underlying blepharitis or MGD with regular warm compresses and omega‑3 supplements.
  • Stay hydrated and use preservative‑free artificial tears in dry environments.
  • Schedule routine eye exams at least once a year, or more often if you have chronic ocular surface disease.

Emergency Warning Signs

Call emergency services or go to the nearest emergency department if you notice any of the following:
  • Sudden, severe eye pain that does not improve with lubricants.
  • Rapidly spreading redness or swelling involving the whole eye (orbital cellulitis).
  • Vision loss or sudden decrease in visual acuity.
  • Presence of pus or thick discharge combined with fever (>38 °C / 100.4 °F).
  • Proptosis (bulging of the eye) or restricted eye movement.
These signs may indicate infection, abscess formation, or a more serious ocular condition that requires immediate medical attention.

References

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References